AU2003902354A0 - Treatment of haemorrhagic shock - Google Patents
Treatment of haemorrhagic shockInfo
- Publication number
- AU2003902354A0 AU2003902354A0 AU2003902354A AU2003902354A AU2003902354A0 AU 2003902354 A0 AU2003902354 A0 AU 2003902354A0 AU 2003902354 A AU2003902354 A AU 2003902354A AU 2003902354 A AU2003902354 A AU 2003902354A AU 2003902354 A0 AU2003902354 A0 AU 2003902354A0
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- haemorrhagic shock
- haemorrhagic
- shock
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010049771 Shock haemorrhagic Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003902354A AU2003902354A0 (en) | 2003-05-15 | 2003-05-15 | Treatment of haemorrhagic shock |
| AU2004238089A AU2004238089A1 (en) | 2003-05-15 | 2004-05-14 | Treatment of haemorrhagic shock using complement 5a receptor inhibitors |
| PCT/AU2004/000642 WO2004100975A1 (en) | 2003-05-15 | 2004-05-14 | TREATMENT OF HAEMORRHAGIC SHOCK USING COMPLEMENT 5a RECEPTOR INHIBITORS |
| EP04732886A EP1635857A1 (en) | 2003-05-15 | 2004-05-14 | TREATMENT OF HAEMORRHAGIC SHOCK USING COMPLEMENT 5a RECEPTOR INHIBITORS |
| JP2006529441A JP2006528208A (ja) | 2003-05-15 | 2004-05-14 | コンプリメント5a受容体阻害剤を使用する出血ショックの処置 |
| CA002557615A CA2557615A1 (en) | 2003-05-15 | 2004-05-14 | Treatment of haemorrhagic shock using complement 5a receptor inhibitors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003902354A AU2003902354A0 (en) | 2003-05-15 | 2003-05-15 | Treatment of haemorrhagic shock |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003902354A0 true AU2003902354A0 (en) | 2003-05-29 |
Family
ID=31501223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003902354A Abandoned AU2003902354A0 (en) | 2003-05-15 | 2003-05-15 | Treatment of haemorrhagic shock |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1635857A1 (https=) |
| JP (1) | JP2006528208A (https=) |
| AU (1) | AU2003902354A0 (https=) |
| CA (1) | CA2557615A1 (https=) |
| WO (1) | WO2004100975A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS54998B1 (sr) | 2008-12-22 | 2016-11-30 | Chemocentryx Inc | Antagonisti c5ar |
| RS56332B1 (sr) | 2010-06-24 | 2017-12-29 | Chemocentryx Inc | Antagonisti c5ar |
| DK3200791T3 (da) | 2014-09-29 | 2020-05-25 | Chemocentryx Inc | Fremgangsmåder og mellemprodukter i fremstilling af C5AR- antagonister |
| JP7339733B2 (ja) | 2016-01-14 | 2023-09-06 | ケモセントリックス,インコーポレイティド | C3腎症を処置する方法 |
| EP3439658B1 (en) | 2016-04-04 | 2021-11-24 | ChemoCentryx, Inc. | Soluble c5ar antagonists |
| US10562896B2 (en) | 2017-05-31 | 2020-02-18 | Chemocentryx, Inc. | 6-5 fused rings as C5a inhibitors |
| WO2018222601A1 (en) | 2017-05-31 | 2018-12-06 | Chemocentryx, Inc. | 5-5 FUSED RINGS AS C5a INHIBITORS |
| CA3077395A1 (en) | 2017-10-30 | 2019-05-09 | Chemocentryx, Inc. | Deuterated compounds as immunomodulators |
| WO2019126424A1 (en) | 2017-12-22 | 2019-06-27 | Chemocentryx, Inc. | DIARYL SUBSTITUTED 6,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS |
| MX2020006460A (es) | 2017-12-22 | 2020-11-06 | Chemocentryx Inc | Compuestos de anillo 5,5 fusionado sustituido con diarilo como inhibidores de c5ar. |
| BR112020019822A2 (pt) | 2018-04-02 | 2021-03-16 | Chemocentryx, Inc. | Profármacos de antagonistas bicíclicos fundidos de c5ar |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO755097A0 (en) * | 1997-06-25 | 1997-07-17 | University Of Queensland, The | Receptor agonist and antagonist |
-
2003
- 2003-05-15 AU AU2003902354A patent/AU2003902354A0/en not_active Abandoned
-
2004
- 2004-05-14 WO PCT/AU2004/000642 patent/WO2004100975A1/en not_active Ceased
- 2004-05-14 CA CA002557615A patent/CA2557615A1/en not_active Abandoned
- 2004-05-14 EP EP04732886A patent/EP1635857A1/en not_active Withdrawn
- 2004-05-14 JP JP2006529441A patent/JP2006528208A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1635857A1 (en) | 2006-03-22 |
| JP2006528208A (ja) | 2006-12-14 |
| CA2557615A1 (en) | 2004-11-25 |
| WO2004100975A1 (en) | 2004-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG24420A (en) | Treatment of ophthalmic conditions | |
| AU2004203785A1 (en) | Treatment of aqueous suspensions | |
| AU2002257936A1 (en) | Methods of well treatment | |
| EP1617844A4 (en) | TREATMENT OF NEUROLOGICAL DISEASES | |
| AU2003902354A0 (en) | Treatment of haemorrhagic shock | |
| AU2003268923A1 (en) | Treatment of aml | |
| AU2002952086A0 (en) | Treatment of osteoarthritis | |
| AU2002952129A0 (en) | Treatment of hypersensitivity conditions | |
| AU2003231803A1 (en) | Treatment of cancer with mefloquire | |
| AU2003238175A1 (en) | Treatment of serious infections and septic shock | |
| AU2003207315A1 (en) | Treatment of muscle damage | |
| GB0217493D0 (en) | Novel methods of treatment | |
| GB0221712D0 (en) | Methods of treatment | |
| AU2003902586A0 (en) | Treatment of burns | |
| AU2003246977A1 (en) | Oil well treatment | |
| GB0327975D0 (en) | Methods of treatment | |
| AU2003281836A1 (en) | Implant for the treatment of presbyopia | |
| AU2003217862A1 (en) | Treatment of septic shock | |
| AU2003271712A1 (en) | Treatment of amm | |
| AU2003272553A1 (en) | Treatment of schizophrenia | |
| HK1085406A (en) | Treatment of neurological conditions | |
| AU2003904161A0 (en) | Methods of treatment | |
| PT1706094T (pt) | Tratamento de condições oftalmológicas | |
| AUPS219902A0 (en) | Methods of treatment | |
| AU2003260254A1 (en) | Piece of jewelry |